{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:58:16Z","timestamp":1792090696059,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To explore patients\u2019 experiences navigating the Standardized Care Pathway (SCP) for macroscopic hematuria through semi-structured interviews.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and materials<\/jats:title>\n            <jats:p>An interview study was conducted to explore patients\u2019 experiences of SCP for macroscopic hematuria. The study employed content analysis with an inductive approach, as described by Lundman and Graneheim, to explore both explicit and implicit patterns in the data. Informants were recruited from an outpatient clinic for investigation of macroscopic hematuria, with interview questions derived from literature and clinical experience. Researchers immersed themselves in the data through repeated readings of transcripts, identifying meaning units that were coded and analyzed to develop subcategories reflecting similarities and differences.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twelve patients, with a median age of 71 years (58% women), participated in the study. Among them, one was diagnosed with urinary bladder cancer (UBC). The findings highlight a mix of appreciation and questioning associated with the SCP process, as patients valued the efficiency of one stop policy for testing but also experienced heightened anxiety. A lack of detailed and patient-centred communication emerged as a key issue, with primary care centers providing insufficient information.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Although SCP is effective, it prompts consideration of whether it is suitable for all patients. A more individually tailored approach might be more appropriate, prioritizing rapid evaluation for those with a high likelihood of cancer while directing others to a standard diagnostic route. Continuing the one-stop policy was seen as beneficial.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12894-025-01898-1","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T05:09:45Z","timestamp":1755925785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patients\u2019 experiences of a standardized care pathway for suspected bladder cancer due to macroscopic hematuria"],"prefix":"10.1186","volume":"25","author":[{"given":"Lisa","family":"Karlsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Ek-Steinum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleiman","family":"Abuhasanein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"1898_CR1","doi-asserted-by":"publisher","first-page":"04109","DOI":"10.7189\/jogh.13.04109","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Rumgay H, Li M, et al. The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040. J Glob Health. 2023;13:04109.","journal-title":"J Glob Health"},{"issue":"1","key":"1898_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, Bruins HM, Cathomas R, et al. European association of urology guidelines on Muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2021;79(1):82\u2013104.","journal-title":"Eur Urol"},{"issue":"2","key":"1898_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234\u201341.","journal-title":"Eur Urol"},{"issue":"578","key":"1898_CR4","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.3399\/bjgp10X515412","volume":"60","author":"M Shapley","year":"2010","unstructured":"Shapley M, Mansell G, Jordan JL, et al. Positive predictive values of >\/=5% in primary care for cancer: systematic review. Br J Gen Pract. 2010;60(578):e366\u201377.","journal-title":"Br J Gen Pract"},{"key":"1898_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/1472-6963-11-284","volume":"11","author":"RP Hansen","year":"2011","unstructured":"Hansen RP, Vedsted P, Sokolowski I, et al. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 2011;11:284.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"1898_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/21681805.2022.2058605","volume":"56","author":"S Abuhasanein","year":"2022","unstructured":"Abuhasanein S, Jahnson S, Aljabery F, et al. Standardized care pathways for patients with suspected urinary bladder cancer: the Swedish experience. Scand J Urol. 2022;56(3):227\u201332.","journal-title":"Scand J Urol"},{"key":"1898_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12955-016-0484-9","volume":"14","author":"E Moseholm","year":"2016","unstructured":"Moseholm E, Rydahl-Hansen S, Overgaard D, et al. Health-related quality of life, anxiety and depression in the diagnostic phase of suspected cancer, and the influence of diagnosis. Health Qual Life Outcomes. 2016;14:80.","journal-title":"Health Qual Life Outcomes"},{"issue":"10","key":"1898_CR8","first-page":"3877","volume":"27","author":"J Chung","year":"2019","unstructured":"Chung J, Kulkarni GS, Morash R, et al. Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory. Support Care Cancer. 2019;27(10):3877\u201385.","journal-title":"Support Care Cancer"},{"key":"1898_CR9","unstructured":"Norling A. Fakta Om \u00f6ppen h\u00e4lso- och sjukv\u00e5rd, s.k.o. Regioner, editor. Sweden; 2023."},{"issue":"4","key":"1898_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/MOU.0000000000000893","volume":"31","author":"K Zimmermann","year":"2021","unstructured":"Zimmermann K, Mostafaei H, Heidenreich A, et al. Health-related quality of life in bladder cancer patients: general and cancer-specific instruments. Part 1. Curr Opin Urol. 2021;31(4):297\u2013303.","journal-title":"Curr Opin Urol"},{"issue":"2","key":"1898_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMp1611252","volume":"376","author":"E Basch","year":"2017","unstructured":"Basch E. Patient-Reported Outcomes - Harnessing patients\u2019 voices to improve clinical care. N Engl J Med. 2017;376(2):105\u20138.","journal-title":"N Engl J Med"},{"issue":"6","key":"1898_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"4","key":"1898_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/21681805.2018.1498124","volume":"52","author":"M Nilbert","year":"2018","unstructured":"Nilbert M, Bl\u00e4ckberg M, Ceberg J, et al. Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria. Scand J Urol. 2018;52(4):237\u201343.","journal-title":"Scand J Urol"},{"key":"1898_CR14","doi-asserted-by":"publisher","first-page":"100298","DOI":"10.1016\/j.ijnsa.2025.100298","volume":"8","author":"BM Jennings","year":"2025","unstructured":"Jennings BM, Yeager KA. Re-viewing the concept of saturation in qualitative research. Int J Nurs Stud Adv. 2025;8:100298.","journal-title":"Int J Nurs Stud Adv"},{"key":"1898_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nedt.2017.06.002","volume":"56","author":"UH Graneheim","year":"2017","unstructured":"Graneheim UH, Lindgren BM, Lundman B. Methodological challenges in qualitative content analysis: A discussion paper. Nurse Educ Today. 2017;56:29\u201334.","journal-title":"Nurse Educ Today"},{"key":"1898_CR16","unstructured":"Gillham B. Forskningsintervjun: tekniker och Genomf\u00f6rande. Studentlitteratur; 2008."},{"issue":"505","key":"1898_CR17","first-page":"584","volume":"54","author":"CS Cornford","year":"2004","unstructured":"Cornford CS, Harley J, Oswald N. The \u20182-week rule\u2019 for suspected breast carcinoma: a qualitative study of the views of patients and professionals. Br J Gen Pract. 2004;54(505):584\u20138.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"1898_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1108\/09526861211192421","volume":"25","author":"N Ndukwe","year":"2012","unstructured":"Ndukwe N, Borowski DW, Lee A, et al. The two-week rule for suspected colorectal cancer: patient experience and psychological impact. Int J Health Care Qual Assur. 2012;25(1):75\u201385.","journal-title":"Int J Health Care Qual Assur"},{"issue":"3","key":"1898_CR19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.eururo.2015.10.024","volume":"69","author":"J Leal","year":"2016","unstructured":"Leal J, Luengo-Fernandez R, Sullivan R, et al. Economic burden of bladder cancer across the European union. Eur Urol. 2016;69(3):438\u201347.","journal-title":"Eur Urol"},{"issue":"1","key":"1898_CR20","doi-asserted-by":"publisher","first-page":"19535","DOI":"10.1038\/s41598-023-46757-x","volume":"13","author":"S Borg","year":"2023","unstructured":"Borg S, H\u00f6rstedt AS, Carlsson T, et al. Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model. Sci Rep. 2023;13(1):19535.","journal-title":"Sci Rep"},{"issue":"1","key":"1898_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3233\/BLC-170138","volume":"4","author":"T Garg","year":"2018","unstructured":"Garg T, Connors JN, Ladd IG, et al. Defining priorities to improve patient experience in Non-Muscle invasive bladder cancer. Bladder Cancer. 2018;4(1):121\u20138.","journal-title":"Bladder Cancer"},{"issue":"11","key":"1898_CR22","doi-asserted-by":"publisher","first-page":"850","DOI":"10.7196\/SAMJ.2019.v109i11.13827","volume":"109","author":"J Jaumdally","year":"2019","unstructured":"Jaumdally J, Sinha S, Lazarus J, et al. One-stop haematuria clinic: first experience in South Africa. South Afr Med J. 2019;109(11):850\u20133.","journal-title":"South Afr Med J"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01898-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01898-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01898-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:14:37Z","timestamp":1757448877000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01898-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1898"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01898-1","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Swedish Ethical Review Authority (Etikpr\u00f6vningsmyndigheten 2022-01055-01) and was performed in accordance with Good Clinical Practice Guidelines and the Declaration of Helsinki. (the IRB review and determination information\u2013 Supplementary.3)","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors declared that the research was conducted according to the principles of the World Medical Association Declaration of Helsinki \u201cEthical Principles for Medical Research Involving Human Subjects.\u201d. All informants have provided their informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"Clinical trial number: not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"216"}}